Is a complete FRA/5VA research report available?

No complete published report is available for fra/5VA (FRA/5VA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/5VA (FRA/5VA)

Frankfurt Stock Exchange: FRA/5VA · EUR

€45.4

-0.80 (-1.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/5VA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.9B
Net income (ttm)	-820.9M
EPS (ttm)	-€5.99
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -820.9M
EPS (ttm): -€5.99
Market cap: 6.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All FRA/5VA indicators

Market & fundamental data

Available fields

139

Groups with data

Currency

USD

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	507
Employees Change	160%
Employees Change Percent	62.99
Enterprise value	EUR 5.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-30
Market cap	EUR 6.9B
Price	EUR 45.4
Price currency	EUR
Sic	2836
Symbol	fra/5VA
Website	https://vaxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.86%
FCF yield	-10.22%
P/B ratio	2.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -820.9M
Profit Per Employee	EUR -1.6M
ROA	-20.23
Roa5y	-19.26
ROCE	-35.05
ROE	-30.55
Roe5y	-30.11
ROIC	-21.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	65.36%
Cagr3y	4.82%
Cagr5y	20.79%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 2.9B
Cash	EUR 1.5B
Current Assets	EUR 1.6B
Current Liabilities	EUR 212.6M
Debt	EUR 100.9M
Debt Equity	EUR 0.04
Debt FCF	EUR -0.14
Equity	EUR 2.6B
Liabilities	EUR 305.5M
Long Term Assets	EUR 1.3B
Long Term Liabilities	EUR 92.9M
Net Cash	EUR 1.4B
Net Cash By Market Cap	EUR 20.32
Net Cash Growth	2.29%
Net Debt Equity	EUR -0.54
Tangible Book Value	EUR 2.6B
Tangible Book Value Per Share	EUR 18.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.49
Net Working Capital	EUR -138.5M
Quick ratio	7.18
Working Capital	EUR 1.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	65.31%
200-day SMA	42.52
3Y total return	15.17%
50-day SMA	43.86
50-day SMA vs 200-day SMA	50over200
5Y total return	157.14%
All Time High	108
All Time High Change	-55%
All Time High Date	2024-09-10
All Time Low	13.4
All Time Low Change	262.69%
All Time Low Date	2021-05-11
ATR	1.33
Ch YTD	29.26
High	45.4
High52	51
High52 Date	2026-04-08
High52ch	-10.98%
Low	45.4
Low52	24.8
Low52 Date	2025-09-18
Low52ch	83.07%
Ma50ch	10.8%
Price vs 200-day SMA	14.31%
RSI	56.24
RSI Monthly	51.13
RSI Weekly	57.74
Sharpe ratio	1.11x
Sortino ratio	1.88
Total Return	-7.07%
Tr YTD	29.26
Tr1m	9.46%
Tr1w	4.29%
Tr3m	0.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -944.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,212,566%
Shares Insiders	0.49%
Shares Institutions	105.56%
Shares Qo Q	2.25%
Shares Yo Y	7.07%
Short Ratio	8.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -833.6M
Adjusted OCF	-794,552,610
Average Volume	3x
Bv Per Share	18.01
CAPEX	EUR -39M
Ch1m	9.46
Ch1w	4.29
Ch1y	65.31
Ch3m	0.83
Ch3y	15.17
Ch5y	157.1
Ch6m	13.55
Change	-1.73%
Change From Open	0
Close	46.2
Days Gap	-1.73
Depreciation Amortization	14,391,768
Earnings Date	2026-08-07
EBIT	EUR -944.3M
EBITDA	EUR -930M
EPS	EUR -5.99
F Score	1
FCF	EUR -706.8M
FCF EV Yield	-12.86x
Financing CF	522,841,397
Fiscal Year End	December
Founded	2,013
Investing CF	69,927,797
Is Primary Listing	0
Last Earnings Date	2026-02-24
Last Report Date	2026-03-31
Ma150	44.35
Ma150ch	9.59%
Ma20	47.85
Ma20ch	1.57%
Net CF	-74,466,378
Next Earnings Date	2026-08-07
Open	45.4
Ppne	328,285,476.9
Price Date	2026-07-29
Ptbv Ratio	2.66
Relative Volume	434.78x
Share Based Comp	126,794,056
Tr6m	13.55%
Volume	0

FRA/5VA (FRA/5VA)

Coverage state: Market snapshot only — no published research

Generate the first FRA/5VA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/5VA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/5VA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/5VA

Frequently asked questions